Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Current Deferred Revenue (2021 - 2023)

Historic Current Deferred Revenue for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $93000.0.

  • Zymeworks' Current Deferred Revenue fell 9971.77% to $93000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $93000.0, marking a year-over-year decrease of 9971.77%. This contributed to the annual value of $32.9 million for FY2022, which is 0.0% changed from last year.
  • As of Q3 2023, Zymeworks' Current Deferred Revenue stood at $93000.0, which was down 9971.77% from $17.8 million recorded in Q2 2023.
  • In the past 5 years, Zymeworks' Current Deferred Revenue registered a high of $32.9 million during Q4 2021, and its lowest value of $93000.0 during Q3 2023.
  • Over the past 3 years, Zymeworks' median Current Deferred Revenue value was $25.4 million (recorded in 2021), while the average stood at $19.8 million.
  • As far as peak fluctuations go, Zymeworks' Current Deferred Revenue changed by 0.0% in 2022, and later tumbled by 9971.77% in 2023.
  • Over the past 3 years, Zymeworks' Current Deferred Revenue (Quarter) stood at $32.9 million in 2021, then changed by 0.0% to $32.9 million in 2022, then tumbled by 99.72% to $93000.0 in 2023.
  • Its Current Deferred Revenue was $93000.0 in Q3 2023, compared to $17.8 million in Q2 2023 and $2.4 million in Q1 2023.